MENU
+Compare
EMBC
Stock ticker: NASDAQ
AS OF
Nov 28, 02:00 PM (EDT)
Price
$12.76
Change
+$0.19 (+1.51%)
Capitalization
746.33M

EMBC Embecta Corp Forecast, Technical & Fundamental Analysis

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes... Show more

EMBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for EMBC with price predictions
Nov 26, 2025

EMBC in upward trend: 10-day moving average crossed above 50-day moving average on November 20, 2025

The 10-day moving average for EMBC crossed bullishly above the 50-day moving average on November 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EMBC advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

EMBC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 37 cases where EMBC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on November 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EMBC as a result. In of 64 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for EMBC turned negative on November 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at .

EMBC moved below its 50-day moving average on November 25, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMBC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EMBC entered a downward trend on November 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (9.206). P/E Ratio (7.873) is within average values for comparable stocks, (166.359). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.581). EMBC has a moderately high Dividend Yield (0.047) as compared to the industry average of (0.016). P/S Ratio (0.696) is also within normal values, averaging (110.838).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EMBC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EMBC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
EMBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EMBC is expected to report earnings to rise 41.00% to 70 cents per share on February 06

Embecta Corp EMBC Stock Earnings Reports
Q4'25
Est.
$0.70
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.35
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.16
The last earnings report on November 25 showed earnings per share of 50 cents, beating the estimate of 46 cents. With 526.88K shares outstanding, the current market capitalization sits at 746.33M.
A.I.Advisor
published Dividends

EMBC paid dividends on September 15, 2025

Embecta Corp EMBC Stock Dividends
А dividend of $0.15 per share was paid with a record date of September 15, 2025, and an ex-dividend date of August 29, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
300 Kimball Drive
Phone
+1 862 401-0000
Employees
2200
Web
https://www.embecta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFREX41.330.15
+0.36%
DFA Real Estate Securities I
MUIFX34.80N/A
N/A
Nationwide Institutional Service
DCFGX35.07N/A
N/A
Dunham Focused Large Cap Growth C
MXTFX6.94N/A
N/A
Empower Small Cap Value Instl
PGLOX12.14N/A
N/A
T. Rowe Price Global Consumer

EMBC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with WAT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
-7.44%
WAT - EMBC
37%
Loosely correlated
-1.31%
MTD - EMBC
37%
Loosely correlated
-1.29%
AZTA - EMBC
36%
Loosely correlated
-4.80%
RVTY - EMBC
36%
Loosely correlated
-0.86%
A - EMBC
35%
Loosely correlated
-1.80%
More

Groups containing EMBC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
-7.44%
Pharmaceuticals: Other
industry (103 stocks)
36%
Loosely correlated
+0.31%
Pharmaceuticals
industry (377 stocks)
35%
Loosely correlated
+0.35%